TP53 and neoplasm: Contrary to expectations for these morphologically far-advanced tumours, 84% of these tumours were oestrogen receptor positive, 70% were progesterone receptor positive and none revealed a strong c-erbB2 overexpression or p53 accumulation (hallmarks of gene amplification or mutations, respectively).